Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,269
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,852
Class I recallsReasonable probability of serious health consequences
24,397
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of assurance of sterility 2,085 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2

Showing 1,681–1,700 of 17,287 recalls

FDA Recall TerminatedTerminated: April 23, 2026Historical recordClass II

M&S Dental Supply Co LLC., Topical Anesthetic Gel, Benzocaine 20%, Net Wt. 1 oz. (30ml), Manufactured for: M&S Dental Supply Co LL, 105-30 101 Avenue, Ozone Park, NY 11416.

by Keystone Industries

Reason
CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
Published
December 25, 2024
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 23, 2026Historical recordClass II

Gelato, Benzocaine 20% Topical Gel Anesthetic Gel, Net Wt. 1 oz. (30ml), Manufactured by Keystone Industries 480 S. Democrat Rd., Gibbstown, NJ 08027, NDC# 68400-352-30.

by Keystone Industries

Reason
CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
Published
December 25, 2024
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 6, 2025Historical recordClass II

Impossible Foods Inc

Product
Impossible Spicy Ground Sausage Meat from plants 14oz chub,…
Reason
product may contain pieces of metal
Published
December 25, 2024
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 6, 2025Historical recordClass II

Impossible Foods Inc

Product
Impossible Savory Ground Sausage Meat from plants 14oz chub,…
Reason
product may contain pieces of metal
Published
December 25, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20

by Mylan Institutional, Inc.

Reason
Subpotent and Superpotent Drug
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-445-20

by Mylan Institutional, Inc.

Reason
Subpotent and Superpotent Drug
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20

by Mylan Institutional, Inc.

Reason
Subpotent and Superpotent Drug
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20

by Mylan Institutional, Inc.

Reason
Subpotent and Superpotent Drug
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20

by Mylan Institutional, Inc.

Reason
Subpotent and Superpotent Drug
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20

by Mylan Institutional, Inc.

Reason
Subpotent and Superpotent Drug
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60

by Ascend Laboratories, LLC

Reason
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60

by Ascend Laboratories, LLC

Reason
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles (NDC 0378-1811-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count bottles (NDC 0378-1800-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-count bottles (NDC 0378-1817-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

by Viatris Inc

Reason
Superpotent Drug and Subpotent Drug: potency failures obtained
Published
December 18, 2024
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.